Advertisement

Topics

FIVEPRIME Company Profile

00:15 EST 19th December 2018 | BioPortfolio

During the last decade, many groups attempted to use data generated by the Human Genome Project to accelerate biologics discovery, but these early efforts were thwarted by technological limitations.
In 2002, Lewis T. ("Rusty") Williams founded FivePrime to capitalize on this enormous, largely untapped, opportunity. His vision was to collect and screen the entire human secretome - the definitive set of proteins from which all biotherapeutics are derived - through medically-relevant assays, to identify the best proteins for specific clinical indications. Implementing this vision required the integration of multiple breakthrough technologies, biologists willing to embrace a high throughput screening mentality, and substantial resources

Location

1650 Owens StreetSuite 200
San Francisco
California
94158-2216
United States of America

Contact

Phone: 415-365-5600
Fax: 415-365-5601


News Articles [8 Associated News Articles listed on BioPortfolio]

I'm hesitant to get excited about this upcoming STING data because it reminds me of when Bristol and FivePrime talked up the first CSF-1R data ahead of SITC last year. But it is a little unusual for Merck to focus on something brand new like this as much

I'm hesitant to get excited about this upcoming STING data because it reminds me of when Bristol and FivePrime talked up the first CSF-1R data ahead of SITC last year. But it is a little unusual for M...

Five Prime Therapeutics to Present at Leerink Partners Roundtable Series: Rare Disease & Oncology

Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a biotechnology company discovering and developing innovative immuno-oncology protein therapeutics, today announced that A...

Five Prime Therapeutics to Present at 2018 Wells Fargo Healthcare Conference

Five Prime Therapeutics, Inc. (Nasdaq: FPRX), a biotechnology company discovering and developing innovative immuno-oncology protein therapeutics, today announced that Aron ...

Five Prime Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference

Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company discovering and developing innovative immuno-oncology protein therapeutics, today annou...

Five Prime Therapeutics to Present at Goldman Sachs 39th Annual Global Healthcare Conference

Five Prime Therapeutics, Inc. (Nasdaq: FPRX), a biotechnology company discovering and developing innovative immuno-oncology protein therapeutics, today announced that Aron...

Five Prime Therapeutics to Present at 30th Annual Piper Jaffray Healthcare Conference

Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company discovering and developing innovative immuno-oncology protein therapeutics, today annou...

Five Prime Therapeutics to Announce Third Quarter 2018 Financial Results and Host Conference Call on November 6

Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics, ...

Five Prime Therapeutics to Announce Second Quarter 2018 Financial Results and Host Conference Call on August 8

Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics, ...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [4 Associated Companies listed on BioPortfolio]

Five Prime Therapeutics, Inc.

Five Prime Therapeutics, Inc. is a clinical-stage, privately-held company discovering and developing innovative protein and antibody therapeutics. FivePrime is currently in Phase ...

FIVEPRIME

During the last decade, many groups attempted to use data generated by the Human Genome Project to accelerate biologics discovery, but these early efforts were thwarted by technological limitations.In...

Human Genome Sciences, Inc. and FivePrime Therapeutics, Inc.

Five Prime Therapeutics

Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases. Five Prime has develope...

More Information about "FIVEPRIME" on BioPortfolio

We have published hundreds of FIVEPRIME news stories on BioPortfolio along with dozens of FIVEPRIME Clinical Trials and PubMed Articles about FIVEPRIME for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of FIVEPRIME Companies in our database. You can also find out about relevant FIVEPRIME Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record